Boundless Bio Inc. (BOLD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Boundless Bio Inc.

NASDAQ: BOLD · Real-Time Price · USD
1.16
0.00 (0.00%)
At close: Sep 11, 2025, 3:59 PM
1.16
-0.01%
After-hours: Sep 11, 2025, 06:33 PM EDT

Boundless Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.09M 957K 942K 682K
Gross Profit
-1.09M -957K -942K -682K
Operating Income
-73.27M -54.8M -46.47M -25.3M
Interest Income
7.89M 5.28M 668K 96K
Pretax Income
-65.36M -49.43M -45.9M -25.21M
Net Income
-65.36M -49.43M -45.9M -25.21M
Selling & General & Admin
18M 12.16M 9.31M 6.02M
Research & Development
55.27M 41.68M 37.16M 19.28M
Other Expenses
-1.09M n/a -100K -5K
Operating Expenses
72.18M 54.8M 46.47M 25.3M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
73.27M 54.8M 46.47M 25.3M
Income Tax Expense
n/a n/a n/a -96K
Shares Outstanding (Basic)
16.98M 22.24M 22.24M 22.24M
Shares Outstanding (Diluted)
16.98M 22.24M 22.24M 22.24M
EPS (Basic)
-3.85 -2.22 -2.06 -1.13
EPS (Diluted)
-3.85 -2.22 -2.06 -1.13
EBITDA
-64.28M -48.48M -45.53M -24.62M
EBIT
-65.36M -49.43M -45.9M -25.21M
Depreciation & Amortization
1.09M 957K 942K 682K